Trulicity ® (dulaglutide)

This information is intended for UK registered healthcare professionals only as a scientific exchange in response to your search for information. Please refer to the link for full prescribing information: Trulicity Summary of Product Characteristics (SmPC)

Can I use Trulicity® (dulaglutide) in patients with a history of Pancreatitis

Dulaglutide has not been studied in patients with a history of pancreatitis. Consider other antihyperglycemic therapies in patients with a history of pancreatitis.

UK_cFAQ_GLP055_Z1_HISTORY_OF_PANCREATITIS
UK_cFAQ_GLP055_Z1_HISTORY_OF_PANCREATITIS
en-GB

What should I do if a patient shows signs of pancreatitis ?

  • Discontinue dulaglutide therapy if you suspect pancreatitis
  • Do not restart dulaglutide therapy if pancreatitis is confirmed
  • Inform the patients about the characteristic symptoms of acute pancreatitis.

Elevations in pancreatic enzymes alone, without other signs of acute pancreatitis, are not predictive of acute pancreatitis.1

After initiation of dulaglutide, observe patients carefully for signs and symptoms of pancreatitis, including persistent severe abdominal pain.2

References

1Trulicity [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

2Data on file, Eli Lilly and Company and/or one of its subsidiaries.

Date of Last Review: October 05, 2020


Contact Lilly

Call or Email us

If you want to ask a Medical Information question or you want to report an adverse event or product complaint you can call us or email us at ukmedinfo@lilly.com

Available Mon - Fri, 10am - 4pm, excluding Bank Holidays

Or you can

Chat with Us

Click to Chat is Offline

If you have a question, you can chat online with a Lilly Medical Information professional.

Submit a request